113 related articles for article (PubMed ID: 19715828)
21. Creatinine reduction ratio: a useful marker to identify medium and high-risk renal transplants.
Vilar E; Varagunam M; Yaqoob MM; Raftery M; Thuraisingham R
Transplantation; 2010 Jan; 89(1):97-103. PubMed ID: 20061925
[TBL] [Abstract][Full Text] [Related]
22. Effect of thymoglobulin in graft survival and function 1 year after kidney transplantation using deceased donors.
Requião-Moura LR; Durão MS; Tonato EJ; Pereira MG; Wroclawski ER; Matos AC; Pacheco-Silva A
Transplant Proc; 2006; 38(6):1895-7. PubMed ID: 16908315
[TBL] [Abstract][Full Text] [Related]
23. Successful simultaneous kidney-pancreas transplantation from extreme donors.
Stratta RJ; Sundberg AK; Farney AC; Rohr MS; Hartmann EL; Adams PL
Transplant Proc; 2005 Oct; 37(8):3535-7. PubMed ID: 16298652
[TBL] [Abstract][Full Text] [Related]
24. Induction with basiliximab in renal transplantation.
Ferrer F; Machado S; Alves R; Macário F; Bastos C; Roseiro A; Mota A
Transplant Proc; 2010 Mar; 42(2):467-70. PubMed ID: 20304166
[TBL] [Abstract][Full Text] [Related]
25. Donor age and outcome of liver transplantation.
Hoofnagle JH; Lombardero M; Zetterman RK; Lake J; Porayko M; Everhart J; Belle SH; Detre KM
Hepatology; 1996 Jul; 24(1):89-96. PubMed ID: 8707288
[TBL] [Abstract][Full Text] [Related]
26. Renal transplantation with expanded criteria donors: the experience of one Portuguese center.
Ferrer F; Mota A; Alves R; Bastos C; Macário F; Figueiredo A; Santos L; Roseiro A; Parada B; Pratas J; Nunes P; Campos M
Transplant Proc; 2009 Apr; 41(3):791-3. PubMed ID: 19376353
[TBL] [Abstract][Full Text] [Related]
27. Renal transplant survival from older donors: a single center experience.
Morrissey PE; Gohh R; Yango A; Gautam A; Monaco AP
Arch Surg; 2004 Apr; 139(4):384-9; discussion 389. PubMed ID: 15078705
[TBL] [Abstract][Full Text] [Related]
28. Induction immunosuppressive therapy in renal transplantation: does basiliximab make the difference?
Jorge S; Guerra J; Silva S; Santana A; Mil-Homens C; Prata MM
Transplant Proc; 2008 Apr; 40(3):693-6. PubMed ID: 18454989
[TBL] [Abstract][Full Text] [Related]
29. Assessment of kidneys procured from expanded criteria donors before transplantation.
Domagala P; Kwiatkowski A; Perkowska-Ptasinska A; Wszola M; Panufnik L; Paczek L; Durlik M; Chmura A
Transplant Proc; 2009 Oct; 41(8):2966-9. PubMed ID: 19857651
[TBL] [Abstract][Full Text] [Related]
30. Effectiveness of Thymoglobulin Induction Therapy in Kidney Transplant From Deceased Donor With Mild to Moderate Acute Kidney Injury.
Lee CH; Gwon JG; Jung CW
Transplant Proc; 2019 Oct; 51(8):2611-2614. PubMed ID: 31474447
[TBL] [Abstract][Full Text] [Related]
31. Basiliximab as an alternative to antithymocyte globulin for early immunosuppression in lung transplantation.
Clinckart F; Bulpa P; Jamart J; Eucher P; Delaunois L; Evrard P
Transplant Proc; 2009 Mar; 41(2):607-9. PubMed ID: 19328937
[TBL] [Abstract][Full Text] [Related]
32. Preemptive kidney transplant from deceased donors: an advantage in relation to reduced waiting list.
Pérez-Flores I; Sánchez-Fructuoso A; Calvo N; Marques M; Anaya S; Ridao N; Rodríguez A; Barrientos A
Transplant Proc; 2007 Sep; 39(7):2123-4. PubMed ID: 17889112
[TBL] [Abstract][Full Text] [Related]
33. The UNOS Scientific Renal Transplant Registry.
Cecka JM
Clin Transpl; 1999; ():1-21. PubMed ID: 11038622
[TBL] [Abstract][Full Text] [Related]
34. Effective immunoprophylaxis with basiliximab plus triple therapy in renal transplantation: five-year single-center experience.
Kandus A; Grego K; Arnol M; Kovac D; Lindic J; Buturović J; Ponikvar R; Bren AF
Transplant Proc; 2006 Nov; 38(9):2853-5. PubMed ID: 17112847
[TBL] [Abstract][Full Text] [Related]
35. Dual kidney transplantation: older donors for older recipients.
Lee CM; Carter JT; Weinstein RJ; Pease HM; Scandling JD; Pavalakis M; Dafoe DC; Alfrey EJ
J Am Coll Surg; 1999 Jul; 189(1):82-91; discussion 91-2. PubMed ID: 10401744
[TBL] [Abstract][Full Text] [Related]
36. Outcomes of kidney transplants from non-heart-beating deceased donors as reported to the Japan Organ Transplant Network from April 1995-December 2003: a multi-center report.
Teraoka S; Nomoto K; Kikuchi K; Hirano T; Satomi S; Hasegawa A; Uchida K; Akiyama T; Tanaka S; Babazona T; Shindo K; Nakamura N
Clin Transpl; 2004; ():91-102. PubMed ID: 16704141
[TBL] [Abstract][Full Text] [Related]
37. Single-center experience in double kidney transplantation.
Fontana I; Magoni Rossi A; Gasloli G; Santori G; Giannone A; Bertocchi M; Piaggio F; Bocci E; Valente U
Transplant Proc; 2010 May; 42(4):1108-10. PubMed ID: 20534235
[TBL] [Abstract][Full Text] [Related]
38. Could prophylactic monoclonal antibody improve kidney graft survival?
Pourmand G; Saraji A; Salem S; Mehrsai A; Nikoobakht MR; Taherimahmoudi M; Rezaeidanesh M; Asadpour A
Transplant Proc; 2009 Sep; 41(7):2794-6. PubMed ID: 19765437
[TBL] [Abstract][Full Text] [Related]
39. Role of donor age and acute rejection episodes on long-term graft survival in cadaveric kidney transplantations.
Emiroğlu R; Yagmurdur MC; Karakayali F; Haberal C; Ozcelik U; Colak T; Haberal M
Transplant Proc; 2005 Sep; 37(7):2954-6. PubMed ID: 16213272
[TBL] [Abstract][Full Text] [Related]
40. Induction therapy with thymoglobulin after heart transplantation: impact of therapy duration on lymphocyte depletion and recovery, rejection, and cytomegalovirus infection rates.
Goland S; Czer LS; Coleman B; De Robertis MA; Mirocha J; Zivari K; Schwarz ER; Kass RM; Trento A
J Heart Lung Transplant; 2008 Oct; 27(10):1115-21. PubMed ID: 18926403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
